Epigral Limited

NSE: EPIGRALINE071N01016₹5,350 Cr

Timeline

Time (IST)	Type	M	Event	Src
10 Nov, 01:28 pm	—	…	Epigral Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Press Release on Un-Audited Financial Results Q2 FY26".	nse
10 Nov, 01:26 pm	—	…	Epigral Limited has informed the Exchange regarding Board meeting held on November 10, 2025.Outcome of Board Meeting held on Monday, 10th November, 2025 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended on 30th September, 2025.	nse
08 Nov, 02:50 pm	—	…	Epigral Limited has informed the Exchange about Participation in Anand Rathi Annual Flagship Conference G-200 Summit on 12.11.2025	nse
05 Nov, 06:06 pm	—	…	Epigral Limited has informed the Exchange about Conference Call on Monday, 10th November, 2025 to discuss Q2 FY26 Results	nse
04 Nov, 11:24 am	—	…	Epigral Ltd - 543332 - Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Second Quarter And Half Year Ended On 30Th September, 2025.	bse
25 Sept, 05:19 pm	—	…	Epigral Limited has informed the Exchange about One-on-One Meeting through V.C. with Investors / Analysts on 26.09.2025, 27.09.2025 and 30.09.2025.	nse
12 Sept, 05:25 pm	—	…	Epigral Limited has informed the Exchange about One-on-One Meeting through V.C.	nse
03 Sept, 05:50 pm	—	…	Epigral Limited has informed the Exchange regarding Resignation of Mr. Sanjay Surendra Jain as Chief Financial Officer of the company w.e.f. September 30, 2025.	nse
03 Sept, 05:47 pm	—	…	Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)	bse